Literature DB >> 13945065

The haemolytic activity of an iron carbohydrate complex.

J FIELDING, G M SMITH.   

Abstract

The haemolytic activity of iron-dextran complex is found to be a function of time, temperature, pH, and concentration. The lytic action is enhanced by small amounts of added ferrous sulphate. The lytic action is inhibited by chelating agents such as citrate and sequestrene salts, which bind ionic iron, but not by ferric citrate or ferric sequestrene which do not bind iron. The ionised iron content of iron-dextran is deduced. The lytic activity of iron-dextran is also inhibited by iron-dextrin and by an iron-sorbitol-citric acid preparation. It is suggested that the iron-sorbitol-citrate molecular complex contains free chelating groups for iron. The significance of these findings for iron-carbohydrate toxicity and metabolism is briefly discussed.

Entities:  

Keywords:  CHELATING AGENTS; CITRATES; HEMOLYSIS; IRON-DEXTRAN COMPLEX; SORBITOL

Mesh:

Substances:

Year:  1963        PMID: 13945065      PMCID: PMC480478          DOI: 10.1136/jcp.16.1.12

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  Intravenous iron-dextrin in iron-deficiency anaemia.

Authors:  J FIELDING
Journal:  Br Med J       Date:  1961-07-29

2.  The role of chelation and binding equilibria in iron metabolism.

Authors:  P CHARLEY; M ROSENSTEIN; E SHORE; P SALTMAN
Journal:  Arch Biochem Biophys       Date:  1960-06       Impact factor: 4.013

3.  The mechanisms of toxicity of some iron preparations.

Authors:  J A NISSIM
Journal:  Br J Pharmacol Chemother       Date:  1954-03

4.  What is the function of transferrin in plasma?

Authors:  C B LAURELL
Journal:  Blood       Date:  1951-02       Impact factor: 22.113

  4 in total
  2 in total

1.  Intravenous iron-dextran: studies on unsaturated iron-binding capacity.

Authors:  J S Cox; G F Moss; I Bremner; J Reason
Journal:  J Clin Pathol       Date:  1968-09       Impact factor: 3.411

2.  Pancytopenia caused by iron-dextran.

Authors:  H Hurvitz; E Kerem; E Gross-Kieselstein; A Brand; D Branski
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.